Your browser doesn't support javascript.
loading
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.
Vanhove, Bernard; Marot, Stéphane; So, Ray T; Gaborit, Benjamin; Evanno, Gwénaëlle; Malet, Isabelle; Lafrogne, Guillaume; Mevel, Edwige; Ciron, Carine; Royer, Pierre-Joseph; Lheriteau, Elsa; Raffi, François; Bruzzone, Roberto; Mok, Chris Ka Pun; Duvaux, Odile; Marcelin, Anne-Geneviève; Calvez, Vincent.
Afiliación
  • Vanhove B; Xenothera, Nantes, France.
  • Marot S; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.
  • So RT; Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Gaborit B; Department of Infectious Disease, Nantes University Hospital, Nantes, France.
  • Evanno G; Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France.
  • Malet I; Xenothera, Nantes, France.
  • Lafrogne G; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.
  • Mevel E; Xenothera, Nantes, France.
  • Ciron C; Xenothera, Nantes, France.
  • Royer PJ; Xenothera, Nantes, France.
  • Lheriteau E; Xenothera, Nantes, France.
  • Raffi F; Xenothera, Nantes, France.
  • Bruzzone R; Department of Infectious Disease, Nantes University Hospital, Nantes, France.
  • Mok CKP; Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France.
  • Duvaux O; Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Marcelin AG; Department of Cell Biology and Infection, Institut Pasteur, Paris, France.
  • Calvez V; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Front Immunol ; 12: 761250, 2021.
Article en En | MEDLINE | ID: mdl-34868003
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Heterófilos / Glicoproteína de la Espiga del Coronavirus / Anticuerpos ampliamente neutralizantes / SARS-CoV-2 / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Heterófilos / Glicoproteína de la Espiga del Coronavirus / Anticuerpos ampliamente neutralizantes / SARS-CoV-2 / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Francia